Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Dermatology · Amelanotic Melanoma

What Does Melanoma Look Like in Albinism?

At a Glance

In people with albinism, melanoma typically lacks pigment and appears as a pink, red, or skin-colored bump, or a bleeding sore. Because visual checks are difficult, patients should use the EFG criteria to feel for spots that are Elevated, Firm, and continually Growing.

In individuals with oculocutaneous albinism type 2 (OCA2), melanomas typically do not look like the dark, brown, or black irregular moles that most people are taught to watch out for [1][2]. Because your body produces very little or no melanin (pigment), if you do develop a melanoma, it is highly likely to be an amelanotic melanoma—a melanoma that lacks typical pigment [1][3]. Rather than appearing as a dark spot, an amelanotic melanoma usually shows up as a pink, red, or skin-colored bump, a scaly patch, or a sore that bleeds and fails to heal [2][4][5].

Because these spots lack pigment, they are notoriously difficult to identify. They are frequently mistaken for harmless skin conditions, bug bites, or other types of skin cancers that are very common in people with albinism, such as squamous cell carcinoma or basal cell carcinoma [6][7][8]. For this reason, relying on the traditional “ABCDE” rule (looking for Asymmetry, irregular Borders, varied Color, large Diameter, and Evolution) is often unhelpful for people with OCA2 [9][10].

How to Spot Amelanotic Melanoma: The EFG Criteria

Because OCA2 also causes severe visual impairment, visually scanning for faint pink patches on pale skin can be incredibly difficult or impossible. Dermatologists recommend using the EFG criteria [9][11]. This tool is specifically designed to catch nodular and amelanotic melanomas [10], and it relies heavily on how a spot feels, making it much more practical if you have low vision. You (or a trusted sighted partner) should check for any spot that has these three features:

  • Elevated: The spot is raised above the surface of your skin [9]. You can feel that it is not flat like a freckle.
  • Firm: The bump feels firm or hard to the touch [9], rather than soft or squishy.
  • Growing: The spot is continually getting larger over time [9][11].

What Else to Watch For and How to Check

In addition to using the EFG criteria, you should be on alert for lesions with the following characteristics:

  • Red or pink patches: They may be ill-defined and look like a patch of irritated skin or a minor rash that won’t go away [2][4].
  • Scaly textures: The surface of the spot might be rough, dry, or peeling [2][12].
  • Unhealing sores: Any sore, ulcer, or scab that bleeds, oozes, or does not completely heal within a few weeks should be evaluated [5][13].

Tips for Self-Exams with Low Vision

  • Rely on touch: When you are in the shower and your skin is wet and soapy, run your hands over your skin to feel for any rough, elevated, or firm spots.
  • Enlist a trusted helper: Have a sighted partner, family member, or caregiver routinely check areas you cannot see or clearly focus on, like your back or scalp.
  • Track changes: If you or a helper spot a suspicious lesion, consider using a smartphone magnifier app or taking reference photos with a coin or ruler next to the spot to accurately track if it is growing before your dermatologist appointment.

Because your visual impairment makes finding these faint spots challenging, and because amelanotic melanomas can mimic harmless spots and tend to be diagnosed at a later stage [14][4], routine professional skin exams are absolutely critical [15][16]. When your dermatologist spots a suspicious pink or red bump, they will likely perform a biopsy (removing a small sample of the tissue) because it is the only definitive way to diagnose an amelanotic melanoma [17][3][18].

Common questions in this guide

What does melanoma look like if you have albinism?
An amelanotic melanoma lacks typical dark pigment. It usually appears as a pink, red, or skin-colored bump, a scaly patch, or a sore that bleeds and fails to heal.
Why is the ABCDE rule unhelpful for people with albinism?
The ABCDE rule relies on finding varied colors and irregular borders in dark moles. Since people with albinism mostly develop pigmentless melanomas and often have low vision, this visual scanning method is usually ineffective.
What are the EFG criteria for checking skin?
The EFG criteria stand for Elevated, Firm, and Growing. It is a screening tool designed to catch nodular and amelanotic melanomas by focusing on how a spot feels, making it highly practical for individuals with visual impairments.
How can I perform a skin self-exam if I have low vision?
You can rely on touch while showering to feel for any rough, elevated, or firm spots on your wet skin. It is also highly recommended to enlist a sighted partner, family member, or caregiver to check areas you cannot clearly focus on.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my visual impairment, how frequently should I be coming in for full-body professional skin exams?
  2. 2.Do you use dermoscopy (a special lighted magnifying tool) to examine my pink or skin-colored spots during my exams?
  3. 3.What is the best way for me to contact your office if I or my caregiver feel a new, firm bump on my skin between scheduled appointments?
  4. 4.Are you experienced in distinguishing between amelanotic melanomas, squamous cell carcinomas, and benign skin lesions in people with albinism?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Amelanotic melanoma of the head and neck: analysis of tumor characteristics from the National Cancer Database.

    Huayllani MT, Boczar D, Saleem HY, et al.

    International journal of dermatology 2021; (60(3)):347-351 doi:10.1111/ijd.15243.

    PMID: 33040374
  2. 2

    Amelanotic melanoma in a patient with oculocutaneous albinism.

    Ruiz-Sanchez D, Garabito Solovera EL, Valtueña J, et al.

    Dermatology online journal 2020; (26(5)).

    PMID: 32621707
  3. 3

    Diagnostic Delays in Metastatic Amelanotic Melanoma Presenting as Breast Pain.

    Do T, Epistola R, Hua DT, et al.

    The American journal of case reports 2020; (21()):e921360 doi:10.12659/AJCR.921360.

    PMID: 32756533
  4. 4

    Polypoid amelanotic melanoma: a diagnostic challenge.

    Milani-Nejad N, Scarbrough C, Mauzo SH, et al.

    Dermatology online journal 2018; (24(8)).

    PMID: 30677854
  5. 5

    Characterizing melanoma in the setting of oculocutaneous albinism: an analysis of the literature.

    Ravichandran S, Funchain P, Arbesman J

    Archives of dermatological research 2023; (315(8)):2413-2417 doi:10.1007/s00403-022-02364-w.

    PMID: 35849167
  6. 6

    Atypical Fibroxanthoma-Like Amelanotic Melanoma: A Diagnostic Challenge.

    Cazzato G, Colagrande A, Cimmino A, et al.

    Dermatopathology (Basel, Switzerland) 2021; (8(1)):25-28 doi:10.3390/dermatopathology8010004.

    PMID: 33445655
  7. 7

    Unsuspected Amelanotic Melanoma in an Elephantiasis Foot.

    Bohara S, Kumar A, Gupta SK, Gupta V

    Indian dermatology online journal 2018; (9(3)):202-203 doi:10.4103/idoj.IDOJ_251_17.

    PMID: 29854646
  8. 8

    Primary myxoid melanoma with dermoscopic findings.

    Uzuncakmak TK, Zindanci I, Zemheri EI, et al.

    Dermatology practical & conceptual 2017; (7(2)):59-61 doi:10.5826/dpc.0702a13.

    PMID: 28515997
  9. 9

    Not all melanomas are created equal: a review and call for more research into nodular melanoma.

    Dessinioti C, Geller AC, Whiteman DC, et al.

    The British journal of dermatology 2021; (185(4)):700-710 doi:10.1111/bjd.20388.

    PMID: 33864261
  10. 10

    Dermatoscopic features of thin (≤2 mm Breslow thickness) vs. thick (>2 mm Breslow thickness) nodular melanoma and predictors of nodular melanoma versus nodular non-melanoma tumours: a multicentric collaborative study by the International Dermoscopy Society.

    Sgouros D, Lallas A, Kittler H, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(11)):2541-2547 doi:10.1111/jdv.16815.

    PMID: 32654237
  11. 11

    The spectrum of morphologic patterns of nodular melanoma: a study of the International Dermoscopy Society.

    Niforou A, Sgouros D, Lallas A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(11)):e762-e765 doi:10.1111/jdv.17428.

    PMID: 34058031
  12. 12

    A rare case of acral amelanotic melanoma, nodular type.

    Mohammed Saeed D, Braniecki M, Groth JV

    International wound journal 2019; (16(6)):1445-1449 doi:10.1111/iwj.13212.

    PMID: 31531925
  13. 13

    Non-melanoma skin cancer in the context of albinism with an associated facial nerve palsy.

    Ngokwe ZB, Bienvenue NND, Stephane NK, et al.

    International journal of surgery case reports 2024; (125()):110628 doi:10.1016/j.ijscr.2024.110628.

    PMID: 39571233
  14. 14

    Matched analysis of the prognosis of amelanotic and pigmented melanoma in head and neck.

    Guo W, Yin G, Liu H, et al.

    Acta oto-laryngologica 2020; (140(9)):785-788 doi:10.1080/00016489.2020.1763456.

    PMID: 32449432
  15. 15

    Clinico-pathologic profile of skin cancers in oculocutaneous albinism at Universitas Academic Hospital.

    Makuru MH, Maruma F, Ngwenya E, Mponda K

    Health SA = SA Gesondheid 2025; (30()):2906 doi:10.4102/hsag.v30i0.2906.

    PMID: 40357250
  16. 16

    Solar Ultraviolet Radiation, Skin Cancer and Photoprotective Strategies in South Africa†.

    Wright CY, Norval M

    Photochemistry and photobiology 2023; (99(2)):509-518 doi:10.1111/php.13676.

    PMID: 35841370
  17. 17

    Amelanotic melanoma recurrence diagnosed by fine-needle aspiration cytology: A case report.

    Khairwa A

    Diagnostic cytopathology 2020; (48(12)):E7-E9 doi:10.1002/dc.24529.

    PMID: 32558348
  18. 18

    Amelanotic Melanocytic Nevus of the Oral Cavity: A Case Report and Literature Review.

    Izzetti R, Minuti F, Pucci A, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(12)) doi:10.3390/diagnostics15121554.

    PMID: 40564874

This page provides educational information on spotting melanoma in individuals with albinism. It is not a substitute for professional medical advice or routine professional skin exams.

Get notified when new evidence is published on Oculocutaneous albinism type 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.